Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ARWR Arrowhead Pharmaceuticals

Watchlist
34.750
+1.470+4.42%
Trading Session  01/31 12:40 ET
High
34.885
Open
33.510
Turnover
8.62M
Low
33.510
Pre Close
33.280
Volume
249.89K
Market Cap
3.71B
P/E(TTM)
Loss
52wk High
56.250
Shares
106.71M
P/E(Static)
Loss
52wk Low
26.810
Float Cap
3.59B
Bid/Ask %
0.00%
Historical High
162.500
Shs Float
103.36M
Volume Ratio
0.76
Historical Low
1.200
Dividend TTM
--
Div Yield TTM
--
P/B
9.30
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.24%
Amplitude
4.13%
Avg Price
34.484
Lot Size
1
Float Cap
3.59B
Bid/Ask %
0.00%
Historical High
162.500
Shs Float
103.36M
Volume Ratio
0.76
Historical Low
1.200
Dividend TTM
--
P/B
9.30
Dividend LFY
--
Turnover Ratio
0.24%
Amplitude
4.13%
Avg Price
34.484
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
CEO: Dr. Christopher Anzalone,PhD
Market: NASDAQ
Listing Date: 06/16/1993
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist